CompletedPhase 3ketamine
Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy
Sponsored by University of Saskatchewan
NCT ID
NCT02987985
Target Enrollment
50 participants
Start Date
2017-10-15
Est. Completion
2020-12-20
About This Study
The objective of this trial is to determine whether an opioid-free general anesthetic (OFA) technique utilizing ketamine, dexmedetomidine, lidocaine, and gabapentin can help reduce postoperative respiratory depression in the post-anesthesia care unit and ward in children with sleep-disordered breathing undergoing tonsillectomy when compared with traditional opioid-containing techniques. It is expected that this OFA regimen will have a measurable reduction on postoperative respiratory depression in children with sleep-disordered breathing.
Conditions Studied
Interventions
- •Acetaminophen, gabapentin
- •Acetaminophen
- •Ketamine , Lidocaine , Dexmedetomidine
- •Fentanyl, Dexmedetomidine
- •Dexamethasone , Ondansetron
- •Sevoflurane
- •Sevoflurane, Fentanyl
Eligibility
Age:N/A - 12 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * Patients aged 0-12 years with Sleep Disordered Breathing (SDB) who are scheduled for elective Tonsillectomy/AdenoTonsillectomy (T/AT) will be recruited at Royal University Hospital, Saskatoon, Saskatchewan. Exclusion Criteria: * age \> 12; American Society of Anesthesiologists (ASA) Classification \> IV; significant cardiorespiratory, neurological, craniofacial, hepatic, renal, or genetic disorders, excluding SDB; concomitant surgical procedures other than myringotomy and tubes; and allergy to any of the study drugs
Study Locations (1)
Royal University Hospital
Saskatoon, Saskatchewan, Canada